As of April 19, 2025, IGM Biosciences (IGMS) has a market cap of $72.926 million USD. According to our data, IGM Biosciences is ranked No.7808 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $72.93 M |
-64.98%
|
Dec 31, 2024 | $0.21 B |
-26.47%
|
Dec 29, 2023 | $0.28 B |
-51.15%
|
Dec 30, 2022 | $0.58 B |
-42.00%
|
Dec 31, 2021 | $1.00 B |
-66.78%
|
Dec 31, 2020 | $3.01 B |
131.37%
|
Dec 31, 2019 | $1.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.74 B |
0.000 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
Market Cap | = | IGMS Stock Price | * | IGMS Shares Outstanding |
= | $1.22 | * | 34.39 M | |
= | $72.93 M |